Tissue Repair Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.339x

Tissue Repair Ltd cash flow conversion efficiency. Based on the latest financial reports, Tissue Repair Ltd (TRP) has a cash flow conversion efficiency ratio of -0.339x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.01 Million ≈ $-2.84 Million USD) by net assets (AU$11.83 Million ≈ $8.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tissue Repair Ltd (2020–2025)

Cash flow conversion efficiency of Tissue Repair Ltd from 2020 to 2025. This chart illustrates how Tissue Repair Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View TRP live share price for real-time trading data and today's change.

Tissue Repair Ltd Cash Flow Conversion Ratio Explained

Tissue Repair Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tissue Repair Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tissue Repair Ltd ranked by their cash flow conversion efficiency. Also see Tissue Repair Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
DGA Spólka Akcyjna WAR:DGA	-0.053x
Ovanti Ltd AU:OVT	-0.245x
Ecclesiastical Insurance Office plc LSE:ELLA	0.006x
PayPoint plc LSE:PAY	0.845x
TechnoDex Bhd KLSE:0132	0.068x
Spacetalk Ltd AU:SPA	-0.153x
Strategic Resources Inc V:SR	-0.008x
J-Long Group Limited NASDAQ:JL	-0.351x

Annual Cash Flow Conversion Efficiency for Tissue Repair Ltd (2020–2025)

The table below shows the annual cash flow conversion efficiency of Tissue Repair Ltd from 2020 to 2025. Review TRP FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$13.91 Million ≈ $9.84 Million	AU$-3.70 Million ≈ $-2.62 Million	-0.266x	+3.12%
2024-06-30	AU$18.04 Million ≈ $12.76 Million	AU$-4.95 Million ≈ $-3.50 Million	-0.274x	-41.14%
2023-06-30	AU$21.88 Million ≈ $15.48 Million	AU$-4.26 Million ≈ $-3.01 Million	-0.194x	-24.24%
2022-06-30	AU$25.34 Million ≈ $17.93 Million	AU$-3.97 Million ≈ $-2.81 Million	-0.157x	-396.87%
2021-06-30	AU$27.07 Million ≈ $19.16 Million	AU$-852.89K ≈ $-603.47K	-0.032x	+95.15%
2020-06-30	AU$999.90K ≈ $707.50K	AU$-649.98K ≈ $-459.91K	-0.650x	--

About Tissue Repair Ltd

AU:TRP Australia Biotechnology

Market Cap

$5.56 Million

AU$7.86 Million AUD

Market Cap Rank

#28280 Global

#1446 in Australia

Share Price

AU$0.13

Change (1 day)

+13.04%

52-Week Range

AU$0.08 - AU$0.41

All Time High

AU$0.70